ISPOR Patient Representative Travel Grants were established to support eligible patient representatives (patients, their caregivers, or representatives from patient organizations) in attending the Society's annual conferences.
Applications for ISPOR Europe 2026 Are Now Being Accepted
Eligibility:
The candidate for the Patient Travel Grant must:
- Represent a nonprofit, voluntary health agency [501(c)3 in the US] with a mission to:
- Combat a particular disease, disability, or group of diseases/disabilities or
- Improve and protect the health of a particular group of people
- Engage in programs, such as, research, education, advocacy, and service to individuals and communities
- Able to provide patient perspectives relevant to health policy, health technology assessment, and/or research and development (ie clinical trials, therapy development, etc.)
- NOT be employed by health technology producers (biopharmaceutical, medical device, or diagnostic companies)
Nature of Grant:
The recipient of the ISPOR Travel Grant receives complimentary registration to the conference and a fixed-amount travel reimbursement, per the ISPOR Travel Reimbursement Policy.
Selection Timeline:
Selection Timeline for ISPOR Europe 2026 Travel Grants
| Application Open | Wednesday, July 22, 2026 |
| Application Deadline | Friday, September 4, 2026 |
| Announcement | Friday, September 25, 2026 |
ISPOR Patient Representatives Travel Grant Awardees
ISPOR 2026 - May 17-20, 2026
- Eva Maria Ruiz de Castilla, Latin America Patients Academy, Peru
- Morgan Salmon, Patient Advocate For Obesity, United States
- Tracey Sikora, National Organization for Rare Disorders, United States
- Aline Silveira Silva, Patient Voices Network and Patient and Citizen Involvement in HTA Interest Group, Canada
ISPOR Europe 2025 - November 9-12, 2025
- Francesco Moretti, ANED - Associazione Nazionale Emodializzati Dialisi e Trapianto APS, Italy
- Francois Houyez, European Organisation for Rare Diseases (Eurordis), France
- Eilidh Duncan, Myeloma Patients Europe, United Kingdom
- Jan Anders Istad, Norwegian MS Society, Norway
- Kate Morgan, Myeloma Patients Europe, United Kingdom
- Mandy Daly, Irish Neonatal Health Alliance, Ireland
- Vasiliki-Rafaela Vakouftsi, Hellenic Society of Crohn’s Disease’s and Ulcerative Colitis’ Patients, Greece
ISPOR 2025 - May 13-16, 2025
- Jaymee Maaghop, Gastrointestinal Society, Canada
- Alisa Casavant, Arthritis Foundation, United States
- Ysabel Duron, The Latino Cancer Institute, United States
- Camilla Tajzler, Canadian Kidney Cancer information system (CKCis), McGill University, Canada
- Paige Nues, International Rett Syndrome Foundation, United States
- Emma Kinloch, Salivary Gland Cancer UK, United Kingdom
- Tina Aswani-Omprakash, South Asian IBD Alliance, United States
- Tiffany Westrich-Robertson, AiArthritis (International Foundation for Autoimmune & Autoinflammatory Arthritis), United States
- Patil Mksyartinian, Colorectal Cancer Canada, Canada
ISPOR Europe 2024 - November 17-20, 2024
- Bettina Ryll – Melanoma Patient Network Europe, Sweden
- Derick Mitchell - Irish Platform for Patient Organisations, Science & Industry (IPPOSI), Ireland
- Finn McCartney - The European Patients’ Academy on Therapeutic Innovation (EUPATI), Netherlands
- Lotte Klim – Denmark
- Marzena Nelken - Krajowe Forum Orphan, Poland
- Mirjana Babamova - FEMINA M, Association for Help and Support of Patients with Gynecological Diseases, Macedonia
- Nabin Paudel - Retina International, Ireland
- Petra Adámková - ONKO Unie/Cancer Patients Voice, Czech Republic
- Sabrina Hanna - The Cancer Collaborative, Canada
- Sara Rossi - European Patient Advocacy Institute (EPAI), Italy
- Silke Schoch - National Health Council, United States
- Sybelle Drumond - ACAMRJ, Brazil
ISPOR 2024 - May 5-8, 2024
- Ryan Fischer, Foundation for Angelman Syndrome Therapeutics (FAST), United States
- Kate Avery, Beyond Celiac, United States
- Olufunke Akiyode, Shout Global Health, United States
- Ella Balasa, Patient Advocate , United States
- Tiffany Westrich-Robertson, AiArthritis (International Foundation Autoimmune & Autoinflammatory Arthritis), United States
- Kimberly Richardson, Black Cancer Collaborative, United States
- Ushma Patel, Patient Advocate, United States
- Stephanie Steele, Immune Deficiency Foundatino, United States
- Gail Attara, Gastrointestinal Society, Canada
- Alma Robles Avila, Guatemalan Association of Heroes of Hope for Cancer Patients, Guatemala
- Angie Botto-van Bemden, Musculoskeletal Research International, United States
- Veronica Stasiak Bednarczuk de Oliveira, Unidos pela Vida - Brazilian Institute of Cystic Fibrosis Care, Brazil
- Marjorie Morrison, Lymphoma Coalition, Canada
- Jason Harris, National Psoriasis Foundation, United States
- Kevin Wake, Uriel E. Owens Sickle Cell Disease Association of the Midwest, United States
ISPOR Europe 2023 - November 13-15, 2023
- Omar A. Escontrias, National Health Council, United States
- Birgitta Termander, Rare Diseases Sweden, Sweden
- Stavros Terzakis, Union of Heart Patients of Navy Officers, Coast Guard and Friends, Hellenic Navy, Greece
- Ana-Ecaterina Amariutei, European Patient Advocacy Institute, Germany
- Richard Ballerand, European Institute for Innovation and Technology, United Kingdom
- Jennifer Camaradou, Health ClusterNET, Netherlands
- Marjorie Morrison, Lymphoma Coalition, Canada
ISPOR 2023 - May 7-10, 2023
- Lisa Machado, Canadian CML Network, Canada
- Sneha Dave, Generation Patient, United States
- Jason Harris, National Psoriasis Foundation, United States
- Ashley Valentine, Sick Cells, United States
- Kevin Wake, Uriel E. Owens Sickle Cell Disease Association of the Midwest, United States
- Anna Hyde, Arthritis Foundation, United States
Virtual ISPOR Europe 2022 - 6-9 November, 2022
- Valentina Strammiello, European Patients Forum, Belgium
- Stefan Živković, National Organisation for Rare Diseases of Serbia, Serbia
- Ananda Plate, Myeloma Patients Europe, Germany
- Tina Mesarič, University of Maribor, Slovenia
- Merce Cases, European Patient Advocacy Institute, Germany
- Sara Pérez Martínez, Freelance Patient Advocate, Spain
- Laura Gumbert, SMA Europe, Bayreuth, Germany
- Sara Loud, Accelerated Cure Project, Inc., United States
- Veronica del Gragnano Stasiak Bednarczuk de Oliveira, Unidos pela Vida-Brazilian Institute of Cystic Fibrosis Care, Brazil
- Anne-Pierre Pickaert, Care 4 Access, France
- Angie Botto-van Bemden, Musculoskeletal Research International Patient Advocate, United States
- Karla Ruiz de Castilla, Esperantra, Peru
Patient Representatives from nonprofit or volunteer organizations can email us for more information about Patient Representative Travel Grants.